A novel 'learning while doing' clinical trial approach called REMAP helps doctors find the optimal trade-off between quickly adopting new therapies during a pandemic, such as the anti-malarial drug hydroxychloroquine, and waiting until they are tested in longer clinical trials. The trial learns from similar trials enrolling around the world and uses artificial intelligence to quickly arrive at answers.
from Top Technology News -- ScienceDaily https://ift.tt/3cc5KjT
Thursday 9 April 2020
Global trial fast tracks testing of hydroxychloroquine, other COVID-19 therapies
Posted By: Unknown - April 09, 2020About Unknown
Magazine Power Theme is officially developed by Templatezy Team. We published High quality Blogger Templates with Awesome Design for blogspot lovers.The very first Blogger Templates Company where you will find Responsive Design Templates.
Subscribe to:
Post Comments (Atom)
SOCIALIZE IT →